Allogene Therapeutics Inc... (ALLO)

AI Score

Unlock

1.80

-0.15 (-7.69%)

At close: Mar 03, 2025, 3:59 PM

1.79

-0.56%

After-hours: Mar 03, 2025, 07:09 PM EST

Allogene Therapeutics Balance Sheet Statement

Table Mode

Year	FY23	FY22	FY21	FY20	FY19	FY18	FY17
Cash & Equivalents	83.16M	576.47M	809.48M	1.03B	588.86M	721.35M	n/a
Short-Term Investments	365.54M	455.42M	283.99M	644.56M	355.41M	366.95M	n/a
Long-Term Investments	3.65M	59.15M	370.18M	207.95M	63.21M	261.97M	n/a
Other Long-Term Assets	16.9M	32.67M	-322.05M	14.62M	8.92M	1.54M	n/a
Receivables	n/a	n/a	n/a	n/a	2.4M	3.11M	n/a
Inventory	n/a	-62.45M	-20.02M	-207.01M	-60.73M	-261.97M	n/a
Other Current Assets	10.42M	11.5M	8.02M	10.62M	11.64M	5.49M	n/a
Total Current Assets	459.12M	528.82M	809.48M	845.13M	544.58M	467.98M	n/a
Property-Plant & Equipment	163.18M	196.43M	181.02M	160.13M	100.94M	41.61M	n/a
Goodwill & Intangibles	n/a	n/a	n/a	n/a	151K	754K	n/a
Total Long-Term Assets	183.72M	288.25M	229.15M	382.7M	173.23M	305.87M	n/a
Total Assets	642.84M	817.08M	1.04B	1.23B	717.8M	773.86M	n/a
Account Payables	5.9M	13.89M	10.26M	10.39M	9.25M	12.34M	n/a
Deferred Revenue	86K	885K	423K	38.99M	n/a	n/a	n/a
Short-Term Debt	6.78M	6M	3.2M	2.97M	1.68M	n/a	n/a
Other Current Liabilities	24.32M	33.84M	34.72M	41.96M	22.15M	17.12M	2K
Total Current Liabilities	37.08M	54.52M	48.17M	94.32M	33.08M	29.46M	2K
Long-Term Debt	88.35M	95.12M	69.93M	50.81M	51.35M	34.46M	n/a
Other Long-Term Liabilities	5.18M	5.85M	4.13M	3.08M	4.35M	6.78M	n/a
Total Long-Term Liabilities	93.53M	96.69M	74.05M	53.89M	55.7M	41.23M	n/a
Total Liabilities	130.6M	151.21M	122.23M	148.21M	88.78M	70.69M	2K
Total Debt	95.12M	95.12M	69.93M	53.78M	51.35M	34.46M	n/a
Common Stock	169K	144K	142K	140K	124K	121K	26K
Retained Earnings	-1.56B	-1.24B	-903.35M	-646.34M	-396.12M	-211.53M	-23K
Comprehensive Income	-955K	-9.93M	-2.57M	268K	1.15M	306K	-5K
Shareholders Equity	512.23M	665.87M	916.41M	1.08B	629.02M	703.16M	-2K
Total Investments	369.19M	514.57M	654.17M	852.5M	418.62M	628.92M	n/a